Medication info
Lipitor Tablet (Atorvastatin Calcium Trihydrate)

Lipitor Tablet (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›10.36mg / 1 tablet
Manufacturer / importer
Sungwon Adcock Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201307382 · Approved 2013.05.20 · Insurance code 664900960

Summary

Main use
Improvement of hyperlipidemia, improvement of familial hypercholesterolemia in children, prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg is for patients requiring an LDL cholesterol reduction of 45% or more). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial dose and maintenance dose of this medicine should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL-apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.
Child dose
2. Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients). The dose should be adjusted at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Sungwon Adcock Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia, improvement of familial hypercholesterolemia in children, prevention of cardiovascular disease

  • Multiple risk factors for coronary artery disease
  • myocardial infarction
  • stroke
  • revascularization
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • type 2 diabetes
  • non-fatal myocardial infarction
  • fatal and non-fatal stroke
  • congestive heart failure
View approved original text

This medication helps reduce the risk of cardiovascular diseases. In particular, it decreases the risks of myocardial infarction and stroke, as well as lowers the risk of revascularization and angina. It is also effective in preventing cardiovascular complications in diabetic patients. Additionally, it is used to reduce cholesterol and triglyceride levels and increase HDL cholesterol levels in the treatment of hyperlipidemia. It is used for pediatric patients with certain familial hypercholesterolemia aged 10 to 17 years. This medication is used to improve cardiovascular health and manage blood lipid levels.

How to take

Adult dose

Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg is for patients requiring an LDL cholesterol reduction of 45% or more). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial dose and maintenance dose of this medicine should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL-apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.

Child dose

2. Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients). The dose should be adjusted at intervals of 4 weeks or longer.

Precautions

This medication should be discontinued immediately if unusual symptoms appear in the muscles. If muscle pain or weakness is severe or if creatine kinase levels significantly increase, treatment should be stopped and a doctor should be consulted. This medication should not be used in individuals with certain diseases or pregnant women, as well as in children under 10 years of age. In particular, patients with liver diseases, muscle disorders, or those taking certain antiviral medications should avoid this medication. Patients with a history of alcohol abuse, poor liver function, elderly patients, and patients with impaired kidney function should use this medication with caution and require monitoring for muscle-related symptoms. While on this medication, regular liver function tests and muscle-related tests should be conducted, and any unusual symptoms should be reported to a doctor immediately. This medication may interact with various other drugs, so if you are taking other medications, you must inform your doctor or pharmacist. Care is especially needed when taken with certain antibiotics, antifungals, antiviral medications, some antihypertensives, oral contraceptives, grapefruit juice, etc. Women who are pregnant or may become pregnant must ensure proper contraception while taking this medication, and should discontinue use immediately if pregnancy is confirmed. Women who are breastfeeding should also avoid this medication. In the case of children or elderly patients, the safety and efficacy of this medication have not been adequately studied, therefore special caution is needed when using it. In case of overdose, there is no specific antidote, so treatment should be symptomatic, and liver function and muscle condition should be closely monitored. This medication should be kept out of the reach of children and stored in its original container, and the container should not be changed arbitrarily.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • nasopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 156 more
  • loss of appetite
  • constipation
  • abdominal bloating
  • indigestion
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngalgia
  • laryngalgia
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • dysgeusia
  • memory loss
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • pruritus
  • hair loss
  • vascular edema
  • angioedema
  • erythema multiforme
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • elevated serum CK
  • urinary leukocyte positivity
  • leukopenia
  • anemia
  • testosterone deficiency
  • elevated cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • increased potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • vomiting
  • abdominal abnormalities
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test results
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcers
  • dysphagia
  • melena
  • gum bleeding
  • hyperprolactinemia
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory abnormalities
  • vertigo
  • photosensitivity reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperactivity
  • depression
  • hypertonia
  • arthritis
  • mucocele
  • synovitis
  • myasthenia
  • tendon shortening
  • elevated serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcer
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast hypertrophy
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency to urinate
  • abnormal ejaculation
  • uterine bleeding
  • colored urine
  • hypothermia
  • hyperlipidemia
  • facial flushing
  • increased non-protein nitrogen
  • hyperuricemia
  • gingival hypertrophy
  • sleep disorders
  • memory loss
  • depression

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. The storage temperature should be maintained in a room temperature range of 1 to 30 degrees Celsius. Proper storage helps to preserve the effectiveness of the drug for a longer period.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.